Genomic profiling of murine mammary tumors identifies potential personalized drug targets for p53-deficient mammary cancers
Targeted therapies against basal-like breast tumors, which are typically 'triple-negative breast cancers (TNBCs)', remain an important unmet clinical need. Somatic TP53 mutations are the most common genetic event in basal-like breast tumors and TNBC. To identify additional drivers and poss...
Збережено в:
| Автори: | , , , , , , , |
|---|---|
| Формат: | Книга |
| Опубліковано: |
The Company of Biologists,
2016-07-01T00:00:00Z.
|
| Предмети: | |
| Онлайн доступ: | Connect to this object online. |
| Теги: |
Додати тег
Немає тегів, Будьте першим, хто поставить тег для цього запису!
|
Інтернет
Connect to this object online.3rd Floor Main Library
| Шифр: |
A1234.567 |
|---|---|
| Примірник 1 | Доступно |